Active Biotech

Showing 2 posts of 2 posts found.


Teva drops MS and Huntington’s disease drug laquinimod, leaving rights to Active Biotech

September 6, 2018
Medical Communications, Research and Development Active Biotech, Laquinimod, Teva, pharma

Israeli multinational Teva Pharmaceutical has decided to discontinue the development of laquinimod. As such, all rights for the orally administered …


Teva and Active Biotech hit by Phase 3 drug failure

May 8, 2017
Research and Development, Sales and Marketing Active Biotech, Teva

Teva and Active Biotech have been collaborating on the drug laquinimod since 2004 but it now looks like the work put …

Latest content